SG11202109738QA - Recombinant ccn domain proteins and fusion proteins - Google Patents

Recombinant ccn domain proteins and fusion proteins

Info

Publication number
SG11202109738QA
SG11202109738QA SG11202109738QA SG11202109738QA SG 11202109738Q A SG11202109738Q A SG 11202109738QA SG 11202109738Q A SG11202109738Q A SG 11202109738QA SG 11202109738Q A SG11202109738Q A SG 11202109738QA
Authority
SG
Singapore
Prior art keywords
proteins
recombinant
fusion proteins
ccn
ccn domain
Prior art date
Application number
Other languages
English (en)
Inventor
Håvard Attramadal
Ole Jørgen Kaasbøll
Original Assignee
Univ Oslo Hf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oslo Hf filed Critical Univ Oslo Hf
Publication of SG11202109738QA publication Critical patent/SG11202109738QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
SG11202109738Q 2019-03-20 2020-03-20 Recombinant ccn domain proteins and fusion proteins SG11202109738QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19163970.7A EP3711772A1 (en) 2019-03-20 2019-03-20 Recombinant proteins and fusion proteins
PCT/EP2020/057773 WO2020188081A1 (en) 2019-03-20 2020-03-20 Recombinant ccn domain proteins and fusion proteins

Publications (1)

Publication Number Publication Date
SG11202109738QA true SG11202109738QA (en) 2021-10-28

Family

ID=66102364

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109738Q SG11202109738QA (en) 2019-03-20 2020-03-20 Recombinant ccn domain proteins and fusion proteins

Country Status (12)

Country Link
US (1) US20220144903A1 (ja)
EP (2) EP3711772A1 (ja)
JP (1) JP2022525661A (ja)
KR (1) KR20210142681A (ja)
CN (1) CN113747912A (ja)
AU (1) AU2020243073A1 (ja)
BR (1) BR112021017147A2 (ja)
CA (1) CA3133740A1 (ja)
IL (1) IL285930A (ja)
MX (1) MX2021011407A (ja)
SG (1) SG11202109738QA (ja)
WO (1) WO2020188081A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202212077D0 (en) 2022-08-18 2022-10-05 Tribune Therapeutics Ab Agents that inhibit ccn ligand-induced signalling for treating disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047556A2 (en) * 1998-03-19 1999-09-23 Trustees Of Tufts College Novel heparin-induced ccn-like molecules and uses therefor
FR2858234B1 (fr) * 2003-08-01 2007-09-14 Centre Nat Rech Scient Nouvel agent anti-angiogenique et son utilisation, notamment dans le cadre du traitement des cancers
ES2395260T3 (es) * 2005-01-10 2013-02-11 Rosalind Franklin University Of Medicine And Science Proteína CCN3 para su utilización en el tratamiento y el diagnóstico de enfermedades renales
SI1853631T1 (sl) * 2005-01-24 2016-04-29 Board Of Regents, The University Of Texas System Fuzijski konstrukti, ki zajemajo regijo FC in se vežejo na fosfatidilserine, ter njihova terapevtska uporaba
WO2007033215A2 (en) * 2005-09-12 2007-03-22 The Johns Hopkins University Compositions having antiangiogenic activity and uses thereof
JP2009067678A (ja) * 2005-12-07 2009-04-02 Nihon Nosan Kogyo Kk 結合組織増殖因子に対する抗体又はそれを含む組成物
US20080207489A1 (en) 2007-02-21 2008-08-28 John Castellot Use of CCN5 for treatment of smooth muscle proliferation disorders
EP2424981A2 (en) * 2009-04-30 2012-03-07 Kao Corporation Alkaline protease variants
JP5820378B2 (ja) * 2009-09-09 2015-11-24 ファーマイン コーポレーションＰｈａｒｍａｉｎ Ｃｏｒｐｏｒａｔｉｏｎ 治療剤の送達のための陰イオンコア組成物およびその製造ならびに使用方法
KR101187814B1 (ko) 2010-03-22 2012-10-08 광주과학기술원 심부전 예방 또는 치료용 약제학적 조성물 및 심부전 예방 또는 치료제의 스크리닝 방법
US9114112B2 (en) * 2010-04-02 2015-08-25 Rosalind Franklin University Of Medicine And Science CCN3 and CCN3 peptides and analogs thereof for therapeutic uses
WO2011123858A2 (en) * 2010-04-02 2011-10-06 Rosalind Franklin University Of Medicine And Science Ccn3 peptides and analogs thereof for therapeutic use
MY162489A (en) 2010-12-23 2017-06-15 Janssen Biotech Inc ACTIVE PROTEASE-RESISTANT ANTIBODY Fc MUTANTS
GB201316592D0 (en) 2013-09-18 2013-10-30 Levicept Ltd Fusion protein
CN105396136B (zh) * 2015-11-23 2018-10-30 上海交通大学医学院附属第九人民医院 CCN1（Cyr61）在治疗皮肤损伤及皮肤萎缩相关疾病中的应用
US11319383B2 (en) 2016-03-14 2022-05-03 Universitetet | Oslo Engineered immunoglobulins with altered FcRn binding
US20180127478A1 (en) 2016-09-16 2018-05-10 Wei-Chiang Shen SINGLE CHAIN Fc-DIMER-HUMAN GROWTH HORMONE FUSION PROTEIN FOR IMPROVED DRUG DELIVERY
KR20180099537A (ko) * 2017-02-28 2018-09-05 주식회사 파이안바이오테크놀로지 근섬유모세포의 병리적 활성이 초래하는 섬유증식성 질병 치료제

Also Published As

Publication number Publication date
EP3711772A1 (en) 2020-09-23
AU2020243073A1 (en) 2021-11-11
WO2020188081A1 (en) 2020-09-24
BR112021017147A2 (pt) 2021-11-09
EP3941507A1 (en) 2022-01-26
CA3133740A1 (en) 2020-09-24
MX2021011407A (es) 2022-01-24
US20220144903A1 (en) 2022-05-12
JP2022525661A (ja) 2022-05-18
CN113747912A (zh) 2021-12-03
IL285930A (en) 2021-10-31
KR20210142681A (ko) 2021-11-25

Similar Documents

Publication Publication Date Title
IL288373A (en) flt3l-fc fusion proteins and methods of use
IL279510A (en) Progranulin-FC polypeptide fusion proteins and their uses
EP3806889A4 (en) CYTOKINE-BASED FUSION PROTEINS AND THEIR USES
IL280102A (en) Fusion protein containing PD1-4-1BBL and methods of using it
SI4011908T1 (sl) Ultra dolgo delujoči inzulin-fc fuzijski proteini in postopki uporabe
IL265489B (en) Recombinant binding proteins and their uses
EP3287470A4 (en) Novel recombinant bi-functional fusion protein and preparation and application therefor
EP3891182A4 (en) RECOMBINATION PROTEIN TARGETING PD-L1 AND VEGF
IL284679A (en) Multifunctional chimeric proteins and their use
HUE064376T2 (hu) Ultra-hosszú hatású inzulin-FC fúziós fehérjék és felhasználási eljárások
IL280103A (en) Fusion protein containing SIRPalpha-4-1BBL and methods of using it
EP4085077A4 (en) FUSION PROTEINS FROM GLP-1 AND GDF15 AND CONJUGATES THEREOF
SG11202110400QA (en) Fusion protein and use thereof
ZA202100859B (en) Recombinant protein variants
EP3722305A4 (en) HM-3 FUSION PROTEIN AND USES THEREOF
EP3836959A4 (en) ANTI-ANGIOGENESIS FUSION PROTEIN AND USES ITS
SG11202104912SA (en) Fusion protein and use thereof
GB202201003D0 (en) Fusion polypeptide and use thereof
EP3668551A4 (en) APOM FC FUSION PROTEINS AND USES THEREOF
EP3858866A4 (en) GLP1-FC-FUSION PROTEIN AND CONJUGATE THEREOF
SG11202101904UA (en) Spd-1 variant - fc fusion proteins
IL279057A (en) Antimicrobial fusion proteins containing endolysin and their uses
IL290715A (en) nkg2d fusion proteins and their use
EP3816181A4 (en) IMPROVED FVIII FUSION PROTEIN AND ITS USE
IL285930A (en) Protein domain of recombinant ccn and fusion proteins